Billionaire Pledges to Witness Bitcoin’s Final Halving in 2140
Billionaire Bryan Johnson aims to witness Bitcoin’s last halving in 2140, aligning longevity research with cryptocurrency.
- Johnson connects anti-aging goals with Bitcoin halving.
- Aims for longevity to 2140.
- Potential shift in crypto and biotech synergy.
Bryan Johnson, a billionaire, has pledged to be present for Bitcoin’s final halving in 2140, connecting longevity ambitions with cryptocurrency at his upcoming Las Vegas conference in May 2025.
Bryan Johnson’s commitment to living until 2140 highlights the potential for merging cryptocurrency with longevity pursuits, promising a convergence of industries.
Billionaire Bryan Johnson has connected his ambitious longevity goals with Bitcoin’s long-term vision by pledging to witness the cryptocurrency’s final halving in 2140. Announcing his intentions on
X, Johnson emphasized combining his
Project Blueprint activities with crypto economics.
Bitcoin’s final halving signifies the conclusion of its emission schedule, a pivotal aspect of its deflationary nature. Johnson’s presence at Bitcoin 2025 in Las Vegas will further underscore this union.
Recent announcements by Johnson, once the CEO of Venmo, underscore his dual interests in biohacking and blockchain technology. He has made it clear that he’s heavily investing in
anti-aging efforts to reach 2140. The significance of Bitcoin’s programmed scarcity relates directly to Johnson’s lifespan extension goals. Experts note that Bitcoin halvings have historically influenced price cycles, adding an economic dimension to Johnson’s longevity narrative. Market reactions to such a long-term promise could influence both the technological and financial sectors.
His pledge has triggered discussions on potential
technological advancements required to achieve such longevity. Johnson’s exploration into regenerative methods, combined with Bitcoin’s economic timeline, offers insight into future possibilities in both fields. The historical trend of Bitcoin halvings may resonate within the bio-tech communities and investors. Observers are keen to assess how these interwoven goals might foster collaboration across emerging industries.
“This event represents a significant milestone in Bitcoin’s monetary policy and is central to its value proposition as a deflationary asset.”
— Bryan Johnson, Primary Investor and Principal Researcher in Project Blueprint
More From Crypto News
Strategy Pauses Bitcoin Buys as STRC Buybacks Continue
Strategy’s latest weekly update showed no new Bitcoin purchase reported, while the company continued repurchasing shares of its STRC preferred stock. The diverg...
Bitcoin Tests $80K as $550M Crypto Liquidations Hit
Bitcoin is testing the $80,000 support level as reports of roughly $550 million in crypto liquidations circulate across market data platforms. Whether BTC can h...
Electrum 4.8.3 Fixes Flaw After Bitcoin Theft
Electrum, one of Bitcoin’s oldest and most widely used software wallets, has released version 4. 8.
Zcash ETFs Draw Millions as Bitcoin Falls
Zcash exchange-traded fund products are reportedly drawing fresh capital at a time when Bitcoin is under selling pressure, with inflows described as the largest...
XRP ETF Investors Put In $1.8B, Holdings Now Worth $1.48B
XRP ETF investors have committed approximately $1. 8 billion in capital, but the aggregate holdings value of those products now sits near $1.
X100 Exploit Proceeds Split Into Four 400-ETH Wallets
X100 exploit proceeds have reportedly been divided into four equal destination wallets, each holding 400 ETH, bringing the observed total distributed across the...
